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ABSTRACT 27 
Ubiquitylation plays an important role in the control of Na+ homeostasis by the kidney. It is 28 
well established that the epithelial Na+ channel ENaC is regulated by the ubiquitin-protein 29 
ligase NEDD4-2, limiting ENaC cell surface expression and activity. Ubiquitylation can be 30 
reversed by the action of deubiquitylating enzymes (DUBs). One such DUB, USP2-45, was 31 
identified previously as an aldosterone-induced protein in the kidney, and is also a circadian 32 
output gene. In heterologous expression systems USP2-45 binds to ENaC, deubiquitylates it 33 
and enhances channel density and activity at the cell surface. Because the role of USP2-45 in 34 
renal Na+ transport had not been studied in vivo, we investigated here the effect of Usp2 gene 35 
inactivation in this process. We demonstrate first that the USP2-45 protein has a rhythmic 36 
expression with a peak at ZT12. Usp2-KO  mice did not show any differences to wild-type 37 
littermates with respect to the diurnal control of Na+ or K+ urinary excretion and plasma levels 38 
neither on standard diet, nor after acute and chronic changes to low and high Na+ diets, 39 
respectively. Moreover, they had similar aldosterone levels either at low or high Na+ diet. 40 
Blood pressure measurements using telemetry did not reveal variations as compared to control 41 
mice. Usp2-KO did not display alterations in proteins involved in sodium homeostasis or the 42 
ubiquitin system, as evidenced by transcriptome analysis in the kidney. Our data suggest that 43 
USP2 does not play a primary role in the control of Na+ balance or blood pressure. 44 
 45 
Keywords: sodium transport, ENaC, blood pressure, circadian rhythm, deubiquitylation  46 
 47 
 48 
  49 
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INTRODUCTION 50 
The kidneys play a major role in the maintenance of blood plasma composition and 51 
volume, achieved by glomerular filtration of large volumes of plasma followed by controlled 52 
reabsorption of the liquid and solutes (7). Of particular interest is the homeostasis of Na+, as 53 
this is critical for determining  blood volume and arterial blood pressure (50). The fine tuning 54 
of the Na+ balance is achieved in the aldosterone-sensitive distal nephron (ASDN) (29) that 55 
includes the late part of the distal convoluted tubule (DCT2), connecting tubule (CNT) and 56 
collecting duct (CD). This process is primarily regulated by the mineralocorticoid hormone 57 
aldosterone (50), which promotes the reabsorption of Na+ by stimulation of transporters and 58 
channels, including the thiazide-sensitive Na+,Cl--cotransporter NCC, the amiloride-sensitive 59 
epithelial Na+ channel ENaC, or the basolateral Na+,K+-ATPase, and stimulates secretion of 60 
K+ via ROMK channels (for a review see (4, 50)). In this context, aldosterone binds in the 61 
cytosol either to its high affinity receptor, the mineralocorticoid receptor (MR) and/or the low 62 
affinity receptor, the glucocorticoid receptor (GR) (2), which then translocate into the nucleus 63 
and promote a transcriptional/translational program involving aldosterone-induced and –64 
repressed proteins. During the past 15 years, considerable progress has been made in the 65 
characterization of these cellular events, and numerous aldosterone-induced proteins have 66 
been identified, including the Serum- and Glucocorticoid-dependent Kinase 1 (SGK1) (10, 67 
33), Glucocorticoid-Induced Leucine Zipper protein GILZ (40), the adaptor protein 14-3-3β 68 
(26), Scaffold Protein Connector Enhancer of Kinase Suppressor of RAS Isoform 3 (CNK3) 69 
(49) or the deubiquitylating enzyme USP2-45 (14). Importantly, evidence has been provided 70 
that these proteins form a complex which may regulate ENaC function via post-translational 71 
modifications including ubiquitylation (i.e. the post-translational modification of target 72 
proteins with ubiquitin (11, 26, 48)). Ubiquitylation is now recognized as an essential 73 
mechanism for regulating cellular and physiological processes (12, 43, 54). It involves the 74 
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action of an enzymatic cascade, including E1 (ubiquitin-activating), E2 (ubiquitin-75 
conjugating) enzymes, and E3 ubiquitin-protein ligases, the latter being the substrate 76 
recognizing enzymes. The process is reversible, implicating deubiquitylating enzymes 77 
(DUBs), such as the Ubiquitin Specific Protease (USP) protein family that comprises close to 78 
60 members (25, 34). With respect to renal Na+ transport, it is now well established that the 79 
ubiquitin-protein ligase NEDD4-2 ubiquitylates either ENaC or NCC and negatively controls 80 
their expression and activity at the plasma membrane (19, 43). Moreover, it has been 81 
discovered recently that mutations in the genes encoding KLHL3 and CULLIN3, which form 82 
a ubiquitin-protein ligase complex, cause pseudohypoaldosteronism type II (PHAII), a rare 83 
form of hypertension involving increased NCC activity (8, 30). As mentioned, the previously 84 
cited aldosterone-induced proteins appear to be all related to the action of NEDD4-2. SGK1 85 
phosphorylates NEDD4-2, creating binding sites for 14-3-3β, and interfering with the 86 
interaction of NEDD4-2 with ENaC (6, 11, 16). Likewise, GILZ and CNK3 are part of the 87 
ERC (epithelial sodium channel regulatory) complex that comprises SGK1 and NEDD4-2 88 
(47).  89 
We had identified previously Usp2-45 as an aldosterone-induced mRNA in a gene 90 
expression screen of microdissected CCD segments from mice that were treated for 1 hour 91 
with aldosterone, or untreated controls. The corresponding gene encodes 2 deubiquitylating 92 
enzymes, USP2-45 and USP2-69, which are generated by different promoters, and alternative 93 
splicing. In Xenopus laevis oocytes, USP2-45 but not USP2-69 increased ENaC activity (14). 94 
Moreover, it was shown in vitro that USP2-45 was able to bind to ENaC, to deubiquitylate the 95 
channel and increase ENaC activity, both by increasing its cell surface expression and by 96 
promoting proteolytic activation (14, 36, 44, 45). Usp2 is also a bona fide circadian output 97 
gene (31, 37-39, 46, 51). In this context, the importance of the circadian clock in renal Na+ 98 
and K+ handling has been highlighted by several reports (13, 35, 53, 57) (for a review see 99 
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(18)). The circadian timing system of mammals is critical to allow anticipation of daily 100 
changes in physiology. It is controlled by cellular, molecular oscillators that regulate the 101 
cyclic expression of output genes (52).  102 
As all the data regarding ENaC regulation by USP2-45 were achieved in heterologous 103 
expression systems, we were interested to know if USP2-45 plays also a role in vivo in ENaC 104 
control. We addressed this question by taking advantage of a total constitutive Usp2 knockout 105 
mouse model (referred to as Usp2-KO), and tested if Na+ and K+ homeostasis are disturbed, 106 
and if blood pressure is misregulated. We found that the Usp2-KO mice are able to perfectly 107 
well handle different Na+ challenges.  108 
  109 
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MATERIAL AND METHODS 110 
 111 
Generation of Usp2 total knockout animals. Usp2-KO mice were generated by Deltagen 112 
(San Mateo CA, USA) by targeting the genomic sequence of mouse chromosome 9 113 
encompassing the last nucleotide of exon 3, all intron 3-4 and the 34 first nucleotides of exon 114 
4. The sequence corresponds to bp 44’089’180 – 44’090’064 on mouse chromosome 9 115 
(RefSeq: NT_039472.8) with a neomycin resistance β-galactosidase cassette. This insertion  116 
targets a stretch of aminoacids containing the catalytic cysteine (C67 and C290 in USP2-45 117 
and -69, respectively) and induces a frameshift. The animals were backcrossed for 10 118 
generations against a pure C57BL6/N genetic background 119 
Genotyping. Genomic DNA from ear biopsy was extracted in 50 mM NaOH and 120 
neutralized in Tris-HCl pH 7.4. 1 µl of this preparation was used for multiplex PCR reaction 121 
with oligonucleotides specific for the endogenous (E), targeted (T) or both allele (E,T): 122 
AAGTGTTGGGCGAGAACTAGTACAG (E,T, sense), 123 
GACGTTGTTTGTCTTCAAGAAGCTTC (T, antisense) and 124 
CAGGAGGGGACTCTGTAAAACTATC (E, antisense) using GoTaq polymerase 125 
(Promega). The PCR products were analyzed on 2% agarose gels. 126 
Reverse transcription PCR and real-time quantitative PCR. Total RNA was extracted 127 
from one half of the left kidney by homogenization in Trizol (Invitrogen) and phenol-128 
chloroform extraction. 2 µg of RNA was reverse-transcribed using Superscript II (Invitrogen) 129 
and 1 µg of random hexamer primers (Applied Biosystems). 20 ng of cDNA was used for 130 
PCR with the following mUsp2 specific primers GCTTCATGAACTCAATTCTTCAG, 131 
GCATGGTTGGTGTTTTCTGAAGC using GoTaq DNA polymerase (Promega). The PCR 132 
products were analyzed on 1% agarose gel. Real time quantitative PCR was performed using 133 
a 7500 Fast Real-Time PCR System (Applied Biosystems) using Usp2-45 oligonucleotides 134 
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and probe described in (14) and Taqman Gene Expression Assays for Sgk1 135 
(Mm00441380_m1) and Gapdh (Mm99999915_g1, Applied-Biosystems). The relative 136 
amount of Usp2-45 and Sgk1 mRNA was normalized to Gapdh mRNA expression. 137 
Gene expression microarray. Kidneys of 8-week old Usp2-KO and wild-type 138 
littermates males were harvested at Zeitgeber time ZT12 (where ZT0 is light onset and ZT12 139 
is light shutoff) and quickly frozen in liquid nitrogen. Total RNA from one half of the left 140 
kidney was extracted using the phenol-chloroform method described above. The obtained 141 
total RNA was then purified using the RNAqueous kit (Ambion). All analysis procedures 142 
were performed by the Lausanne Genomic Technologies Facility. RNA quality and 143 
concentration was verified with an Agilent Bioanalyzer 2100. Equal amounts of RNA 144 
extracted from three mice from the same group were combined as a pool. For all samples, 300 145 
ng of total RNA was used to perform target preparation using the Whole Transcript Sense 146 
Target Labeling Protocol procedure (Affymetrix, High Wycombe, UK). Affymetrix Mouse 147 
Gene 1.0 ST arrays were hybridized with 5 micrograms of labeled, amplified cDNA from two 148 
pools per genotype, washed, stained and scanned on an Affymetrix GeneChip Scanner 7G 149 
according to the protocol described in Affymetrix GeneChip® Expression Analysis Manual 150 
(Fluidics protocol FS450_0007). Gene level normalized expression signals were calculated 151 
from Affymetrix CEL files using RMA (23). Data were finally reported as log2 of the 152 
normalized expression signals and analyzed with two-tailed Student t-test and Benjamini-153 
Hochberg correction for multiple testing. The data were deposited in the NCBI Gene 154 
Expression Omnibus database (accession number: GSE43517). 155 
Metabolic cages. 8-12 week old Usp2 WT and KO mice were fed a normal housing 156 
chow (Kliba-Nafag) and were habituated to 12h light:12 h dark cycles (LD) for at least 2 157 
weeks. The animals were placed in individual metabolic cages (Techniplast, Buguggiate, 158 
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Italy) for body weight, water and food consumption measurements and urine and feces 159 
collections every 4 hours for 32 hours in LD. 160 
For the dietary Na+ challenge experiment the animals were fed a normal Na+ control 161 
diet (0.17% Na+, Ssniff Spezialdiäten GmbH, Soest, Germany) for 2 days and switched to 162 
either Na+ deficient (<0.01%, Ssniff Spezialdiäten GmbH, Soest, Germany) or Na+ rich (3.2% 163 
Na+, Ssniff Spezialdiäten GmbH, Soest, Germany). Body weight, water and food 164 
consumption were measured and urine and feces were collected every 12 hours at ZT1 and 13 165 
and every 6 hours at ZT13, 19, 1 and 7 for 24 hours after diet change. Mice were irreversibly 166 
anesthetized with 0.8 mg Xylazine and 1 mg Ketamine per kg BW in 0.9% NaCl injected 167 
intraperitoneally. Blood was collected by retroorbital punction. The animals were then 168 
sacrificed by cervical dislocation and tissues were harvested and quickly frozen in liquid 169 
nitrogen. 170 
Plasma and urine chemistry. Urinary and plasma Na+ and K+ were measured using a 171 
VG Instrumentation Laboratory 943 automatic flame photometer, urine osmolality with an 172 
Advanced 2020 osmometer (Advanced Instruments) and plasma aldosterone was measured 173 
using a RIA (Coat-a-count Diagnostics Products Inc.). Plasma and urinary creatinine were 174 
measured by the Clinical Chemistry Lab of the University Hospital in Lausanne, using 175 
standard techniques. Glomerular Filtration Rate was calculated on creatinine clearance. 176 
Blood pressure measurements. Briefly, the animals were surged and implanted a 177 
transponder in the carotid artery (Data Science International) as described previously (41). 178 
After a 10-day period of recovery cardiovascular parameters were measured every minute for 179 
9 seconds for 1-5 days in LD cycles. Data were separated into day (ZT0-12) and night (ZT12-180 
0) and mean systolic and diastolic blood pressure were calculated for each animal.  181 
Diurnal tissue collection. Usp2-WT and KO animals were housed for at least 3 weeks in 182 
LD and sacrificed every 4 hours around the clock by decapitation. Sacrifices at ZT12, 16 and 183 
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20 were done under red dim light. Tissues were collected quickly frozen in liquid nitrogen 184 
and stored at -70°C before analysis. 185 
Study approval. All experimental procedures were approved by the Swiss animal 186 
welfare authorities and carried out in accordance with the local animal welfare act. 187 
Statistical analyses. All datasets were first screened for the presence of outliers using 188 
the 1.5 Interquartile Range as exclusion criteria (i.e. data farther than 1.5 IQR above or under 189 
the median of the dataset were considered as outliers and removed of the analysis). Multiple 190 
comparisons were performed by two-way ANOVA and post-hoc two-tailed Student T-tests 191 
were performed using the Holm-Sidak correction of significance threshold for multiple testing 192 
if not stated otherwise. 193 
 194 
  195 
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RESULTS 196 
Characterization of Usp2-KO mice. Usp2-KO mice were purchased from Deltagen and 197 
backcrossed against a C57BL/6N background for more than 10 generations. In these mice, the 198 
last base pair of exon 3, intron 3/4 and exon 4 were targeted with a Lac0-SA-IRES-lacZ-WT 199 
Neo/Kan cassette, leading to the deletion of amino acids TCFMNSILQCLSN, situated at the 200 
beginning of the catalytic domain and including Cys67 in USP2-45 (or Cys290 in USP2-69) 201 
that is essential for enzymatic activity. Both Usp2 splice variants are targeted in these mice 202 
(Fig. 1A). PCR analysis of genomic DNA isolated from the skin demonstrates the 203 
transmission of the KO allele (Fig. 1B), further confirmed by β-galactosidase stainings of 204 
various tissues (data not shown). Moreover, RT-PCR analysis on whole kidney total RNA 205 
extracts demonstrates deletion of Usp2-45 and Usp2-69 (Fig. 1C). At the protein level, 206 
Western blot analysis using either an antibody against the N-terminus of USP2-45 (USP2-207 
45NT), or an antibody against the C-terminal catalytic region shared by both isoforms (USP2-208 
CC), confirmed the deletion of USP2-45 (Fig. 1D,E). Intriguingly, the 2 antibodies did not 209 
recognize bands of similar size. Whereas the N-terminal antibody marked a protein at an 210 
apparent molecular weight of 45 kDa (Fig. 1D), which disappeared in the KO mice, this 45 211 
kDa band was not observable by the C-terminal antibody, due to a crossreacting protein in 212 
this region. In contrast, USP2-CC labeled a protein below 40 kDa (Fig. 1E), which may 213 
represent a proteolytic cleavage product missing the N-terminus, and consequently not 214 
recognizable by the N-terminal antibody. We were not able to detect USP2-69 in the kidney, 215 
consistent with previous findings showing that USP2-69 is not or only very weakly expressed 216 
in this tissue (20). According to the detailed phenotypic analysis provided by Deltagen and 217 
our own observations, homozygote KO mice are viable, and were born at Mendelian ratio, 218 
indicating that Usp2-KO animals do not die prematurely during development. Similarly to 219 
what was described previously with another Usp2-KO model, the fertility of male KO mice 220 
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was strongly reduced (5). The mice did not show any growth defect or any other obvious 221 
morphological changes, as assessed by the mouse phenotyping platform of Deltagen. 222 
 223 
Diurnal expression of USP2-45 in the kidney. As outlined in the introduction, Usp2 is 224 
controlled by the circadian timing system in numerous tissues, including the kidney (24, 38, 225 
39). Thereby the peak of expression of mRNA in mice in constant darkness (DD) is at 226 
Circadian Time 8 to 12 and between ZT12 and 16 in liver and kidney in LD (32, 57) 227 
corresponding to the end of the subjective resting period (39, 46). At the protein level, the 228 
diurnal expression of USP2-45 had been followed previously in the suprachiasmatic nucleus 229 
(SCN) and found to peak at ZT16 (46). We followed USP2-45 every 4 hours in total kidney 230 
lysates, using the anti USP2-45NT antibody and observed that USP2-45 displays a rhythmic 231 
expression in the kidney that peaks at ZT12 in control mice (Fig. 2). No USP2-45 was 232 
detectable at any time point in the KO mice. Our data nicely demonstrate that the protein is 233 
closely following mRNA expression, suggesting that USP2-45 has a short turnover. 234 
 235 
Maintained diurnal rhythm of Na+ and K+ excretion in Usp2 KO mice. As it was 236 
previously proposed that USP2-45 is an aldosterone-induced protein in the kidney, able to 237 
stimulate ENaC expression and activity in heterologous expression systems, including 238 
Xenopus laevis oocytes, renal epithelial cells (mpkCCDcl4 cells) and Hek293 cells (14, 44, 239 
45), we were interested to know if Usp2 KO mice are defective in the regulation of Na+ 240 
homeostasis and other related renal parameters. Because USP2-45 protein is highly rhythmic, 241 
we housed mice in metabolic cages during 24 hours, and recorded water and food intake, 242 
urine volume and creatinine excretion every 4 hours around the clock (Fig. 3 A-D). In both 243 
Usp2 KO mice and control animals, these parameters followed an expected diurnal rhythm 244 
and were maximal at ZT12 to 16, hence at the beginning of the activity period of mice. There 245 
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was no observable difference between the 2 groups of animals (Fig. 3). We looked then at 246 
diurnal rate of Na+ and K+ excretion, which peaked between ZT12-16, and were not different 247 
throughout the day (Fig. 3E-F).  248 
 249 
Usp2-KO mice are able to adapt to dietary salt changes. After having found that there 250 
are no alterations in excretory rates of Na+ or K+, we wondered if there might be a difference 251 
in how mice handle dietary Na+ changes. Animals were switched from a control diet 252 
(containing 0.17 %  of Na+) either to a low (< 0.01% Na+) or high Na+ diet (3.2 % Na+) before 253 
an activity period to ensure an immediate as possible experimental food intake. Na+ or K+ 254 
excretion were measured in metabolic cages over 6 days and half (Fig. 4), by collecting the 255 
urine every 12 hours. As USP2-45 was reported to be induced in the early phase of 256 
aldosterone response, we increased the resolution of the measures on the first 24 hours of 257 
challenge by collecting the urine every 6 hours. As can be seen in Fig. 4, wild-type and Usp2 258 
KO animals were able to handle the switch to either diet by rapidly (6 - 12 hours) adapting 259 
their Na+ excretion rate to the altered Na+ intake. In both groups, K+ excretion was not 260 
affected by the diet change. No difference in either Na+ (Fig. 4A) or K+ excretion (Fig. 4B) 261 
was observed during the entire period and plasma levels of Na+, K+ and were not altered in 262 
Usp2-KO mice (Fig. 5A and B).  In addition, the plasma levels of aldosterone were in the 263 
expected ranges reached under low and high Na+ dietary conditions (Fig. 5C). The analysis of 264 
a number of other metabolic parameters did not show any change as summarized in Table I. 265 
Hence, our data suggest that USP2 does not play a crucial role in the regulation of Na+ or K+ 266 
homeostasis by the kidney (Fig. 5, Table I).  267 
 268 
 269 
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The blood pressure is not changed in Usp2-KO mice. It is well established that 270 
disturbances in Na+ reabsorption cause either hyper- or hypotension (27). We therefore 271 
wondered if suppressing USP2 may influence blood pressure and measured systolic and 272 
diastolic blood pressure by telemetry in mice under low, normal and high Na+ diet (Fig. 6). 273 
Average day or night systolic or diastolic pressures are displayed of control and KO mice. We 274 
did not observe any difference at any period of the day between control and Usp2-KO mice. 275 
Taken together, our data do not reveal any disturbances in Na+ or K+ handling by the kidney, 276 
nor is there any evidence for disturbances in blood pressure regulation. As it is possible that 277 
there are compensatory mechanisms, affecting the ubiquitin system or the Na+ transport 278 
regulation,  if such regulatory pathways are affected.   279 
 280 
Suppression of USP2 is not compensated by proteins involved in the ubiquitin system or 281 
regulation of Na+ homeostasis.  Because we had previously shown that heterologous 282 
expression of USP2-45 regulates ENaC (14, 44, 45), we were wondering if there is come 283 
compensation by proteins involved in ubiquitylation/deubiquitylation or in the control of Na+ 284 
homeostasis.  We therefore carried out gene expression profiling of total kidneys of control or 285 
KO mice, using Affymetrix oligonucleotide arrays. The kidneys were isolated at ZT12, when 286 
USP2-45 is the strongest expressed. Our analysis did not allow us to detect transcriptomal 287 
differences between kidneys of control and Usp2-KO mice.  288 
 289 
Usp2 is not regulated by changes in dietary Na+ intake. We wondered if varying Na+ 290 
diet may change the expression of Usp2-45. We carried out real-time PCR on RNA extracted 291 
from isolated CCD of mice were kept under low, normal of high Na+ diet for 2 weeks, as 292 
described in (28). As one can see in Fig. 9, low Na+ diet increased the expression of Sgk1 293 
mRNA, and high Na+ diet decreased it, whereas these dietary changes had no effect on Usp2-294 
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45 mRNA, indicating that Usp2-45 is not regulated by Na+ intake, at least not under chronic 295 
conditions. 296 
  297 
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DISCUSSION 298 
 299 
It is well accepted that regulation of Na+ homeostasis involves the ubiquitin system. 300 
Indeed, both ENaC and NCC are regulated by post-translational modification comprising 301 
ubiquitin and this ubiquitylation negatively controls the functional expression of these 302 
proteins at the cell surface (19, 42, 43). The importance of this mechanism in the regulation of 303 
ENaC and NCC is documented by the Liddle’s syndrome, in which mutations in the genes 304 
encoding the β and γENaC subunit lead to the inactivation of binding motifs for the ubiquitin-305 
protein ligase NEDD4-2 (1), or in PHAII, where mutations in either CUL3 or in KLHL3, both 306 
subunits of a ubiquitin-protein ligase complex, cause the disease, likely by increasing NCC 307 
activity (8, 30). Ubiquitylation is a reversible process, catalyzed by DUBS. As mentioned in 308 
the introduction, USP2-45 had been identified previously as an aldosterone-induced protein 309 
and shown to regulate ENaC by binding to and deubiquitylating the channel in heterologous 310 
expression systems (14). Therefore, we were interested to know if Usp2-KO mice have 311 
impaired regulation of Na+ homeostasis and blood pressure control. Surprisingly, however, 312 
these mice did not show any sign of disturbed salt or water regulation, nor did they display 313 
troubles in diastolic or systolic blood pressure. 314 
 315 
In mice deficient of USP2, the intron 3 to 4, and exon 4 were targeted, leading to the 316 
frame-shifted replacement of a short stretch of amino acids by a neomycin resistance and β-317 
galactosidase cassette at the beginning of the USP2 catalytic domain, including the 318 
catalytically critical cysteine 67 in USP2-45. PCR analysis on genomic DNA, RT-PCR on 319 
kidney mRNA, and Western blot analysis on kidney lysates (using 2 different antibodies) 320 
confirmed the deletion of USP2. 321 
  322 
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The conclusion that in vivo inactivation of Usp2, and specifically Usp2-45 do not 323 
obviously alter Na+ and K+ homeostasis, nor blood pressure, is based on a number of 324 
experimental evidences: First, KO mice do not show any differences with respect to food and 325 
water intake, nor urine production. Second, we did not observe changes in plasma Na+ or K+ 326 
concentration, or defect in the excretion of these cations, and the mice were perfectly able to 327 
handle either low Na+ or high Na+ diets. This is different for example from Sgk1-KO mice, 328 
which, when kept under low Na+ diet, are wasting salt (16, 17, 55). Moreover, there was no 329 
change in circulating aldosterone levels between control and KO animals, as would be 330 
expected if these animals had a defect in Na+ reabsorption, and were for example 331 
hypovolemic. Again, this is different from Sgk1-KO mice, which have elevated aldosterone 332 
concentrations or from inducible renal tubule-specific Nedd4-2-KO mice, which display salt-333 
sensitive hypertension, increased NCC activity and low aldosterone levels (3, 41). In contrast 334 
to Sgk1 or Nedd4-2-KO mice, Usp2-KO mice are perfectly able to maintain the same diastolic 335 
and systolic blood pressure as WT mice, independent of the time of the day, or the diet (low, 336 
normal or high Na+ diet).  337 
 338 
The finding that Usp2-KO mice do not show any apparent defect in the handling of Na+ 339 
and K+ is unexpected, in the view of previous findings that USP2-45 is an early aldosterone-340 
induced protein. However, in the original screen, the intraperitoneal injection of aldosterone, 341 
achieving 10 nM aldosterone after 30 minutes, induced only a relatively weak increase of 342 
USP2-45 (1.6-fold for mRNA, or 2.4-fold at the protein level), as compared for example to 343 
Sgk1 mRNA, which was increased more than 8-fold (14). Indeed, when looking at the effect 344 
of various Na+ diets (low, normal or high Na+ diets for 10 days), with 0.1 nM aldosterone at 345 
high Na+ and 1 nM at low Na+ diet, we see no effect on the expression of Usp2 mRNA in 346 
microdissected CNT/CCD tubules, whereas Sgk1 mRNA is regulated (Fig. 9). Previously, we 347 
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had also shown that USP2-45 is able to regulate ENaC in vitro. It has to be taken into account, 348 
however, that most of these data were established in heterologous expression systems, such as 349 
Xenopus laevis oocytes, or Hek293 cells. In these situations, overexpression of USP2-45 may 350 
non-specifically deubiquitylate ENaC, and consequently lead to increase of ENaC cell surface 351 
expression and activity. On the other hand, in the kidney, where endogenous USP2-45 is 352 
much more weakly expressed (as judged from immunoblotting), the DUB does not seem to be 353 
involved in sodium transport regulation or its function is so redundant that its absence is 354 
compensated without any overt phenotype.   355 
 356 
It might have been possible that compensatory effects develop in Usp2-KO mice within 357 
regulatory pathways controlling ENaC and/or NCC. Gene expression analysis on total kidney 358 
RNA, using Affymetrix microarrays, did not reveal significant abnormalities in the expression 359 
of any transcript.  Particularly, no enzyme involved in ubiquitylation or deubiquitylation was 360 
changed, even not UCH-L3, encoding a DUB previously proposed to regulated ENaC (9), nor 361 
any of the proteins playing directly or indirectly a role in Na+ homeostasis.  The one exception 362 
is the mineralocorticoid receptor (MR), whose expression appears to be regulated by USP2-45 363 
at the protein level, suggesting a negative feedback loop for limiting the aldosterone response 364 
(15) As we do not observe any effect on Na+ handling, the physiological role of this feedback 365 
regulation remains to be determined. However, a limitation of our study relates to the fact that 366 
the analysis was carried out in whole kidney. Therefore, we cannot exclude that 367 
transcriptional compensatory effects taking place in the ASDN may be masked due to dilution 368 
in the whole tissue. Moreover, we do not know about other mechanisms of gene expression 369 
regulation, such as miRNAs that may be play a compensating role. 370 
 371 
 372 
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To date we can only speculate on the function of USP2-45 in the kidney. As mentioned 373 
above, and also shown in Fig. 2, USP2-45 has a strongly rhythmic expression pattern, with a 374 
peak of expression around ZT12, which is at the end of the resting period. Such a pattern of 375 
expression has been found at the mRNA level in any tissue analyzed, suggesting that USP2-376 
45 plays a role in the rhythmic regulation of physiological processes everywhere in the 377 
organism (24, 38, 39). However, Usp2-KO mice show only relatively minor defects in the 378 
regulation of the circadian clock in general, as evidenced for example by the rhythmic control 379 
of behavior  in running wheels (which we also carried out; data not shown) (46, 56). It is 380 
therefore likely that the rhythmic levels of USP2-45 control diurnal expression of target 381 
proteins, by stabilizing such proteins. It is clear now that the circadian clockwork controls 382 
renal functions, for example the Na+ handling (21, 22, 35), but our data indicate that Usp2 is 383 
not crucial in this process.  384 
 385 
In conclusion, we show here that inactivation of Usp2 in mice does not impair the 386 
ability of the animals to handle Na+ balance, or to control blood pressure. These mice do not 387 
display any sign of compensatory mechanism, neither at the functional level, nor at the 388 
transcriptional level, suggesting that USP2-45 is not playing a key role in these processes.  389 
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FIGURE LEGENDS 595 
Table I. Summary of the metabolic parameters measured on Usp2-WT and KO mice during 596 
the last 24 hours of each  dietary Na+ condition (NSD, LSD, HSD). Data are means ± SD of 597 
12 (NSD) or 5-6 (LSD, HSD) animals per genotype. LSD : Low Sodium Diet <0.01% Na+ ; 598 
NSD : Normal Sodium Diet 0.17% Na+ ; HSD : High Sodium Diet, 3.2% Na+ 599 
Fig. 1. Generation of Usp2 knockout animals. A: The genomic region of the Usp2 gene 600 
coding for the catalytic C67 / C290 of USP2-45 and USP2-69 was replaced by a neomycin 601 
resistance (Neo-R)/β-Galactosidase (LacZ) cassette resulting in a total constitutive knockout 602 
model. B: Genotyping by multiplex PCR yields to DNA fragments of 204 and 531 bp 603 
corresponding to the WT and KO alleles respectively. C: RT-PCR analysis of total RNA 604 
extracted from the kidneys of Usp2 WT and KO animals. 20 ng of retro-transcribed RNA was 605 
assayed for PCR and the DNA products were analyzed on a 1% agarose gel.  (n=4). D,E: The 606 
presence of USP2 protein products in total kidneys was assayed by SDS-607 
PAGE/immunoblotting using two different anti-USP2 antibodies. Anti USP2-45NT (D) was 608 
raised against the specific N-terminal extension of mUSP2-45 whereas anti-USP2-CC (E) was 609 
raised against the common C-terminal catalytic core of both USP2 isoforms. As expected no 610 
USP2 immunoreactive signal was detected in the kidney of the KO animals.  611 
Fig. 2. Renal expression of USP2-45 expression is rhythmic. Kidneys were obtained from 4 612 
WT and 4 KO animals at the indicated Zeitgeber time points (where ZT0 is light onset and 613 
ZT12 is light shutoff). Total kidney protein extracts were assayed for anti-USP2-45 614 
immunoblotting. Shown is a representative western blot out of 4 series. 615 
 Fig. 3. Usp2-KO mice show normal diurnal renal Na+ and K+ handling. Water (A), food 616 
intake (B), urinary volume (C), creatinine (D), Na+ (E) and K+ (F) excretion rates were 617 
26 
 
measured on the indicated Zeitgeber time periods. Data are means ± SD of 12-18 samples 618 
obtained from 12 animals. WT: black bars, KO : gray bars. 619 
Fig. 4. Usp2-KO mice adapt to Na+ dietary challenges. Mice were kept in metabolic cages for 620 
3 days under normal Na+ diet and switched to either low Na+ (LSD, upper panels) or high Na+ 621 
(HSD; lower panels) diet at time 0.  Na+ (A) and K+ (B) excretion rates were calculated at the 622 
indicated time points. Data are means ± SD of 5-6 animals per genotype. WT: black bars, KO: 623 
gray bars; Normal Na+: 0.17% Na+; LSD: Low Na+ diet: < 0.01% Na+; HSD: High Na+ diet: 624 
3.2% Na+.  625 
Fig. 5. Usp2-KO mice maintain normal plasma Na+, K+ and aldosterone. Plasma Na+ (A), K+ 626 
(B) and aldosterone (C) were measured on plasma collected at ZT12 after 7 days of LSD (left 627 
columns) or HSD (right columns) dietary challenge. Data are presented as means ± SD of 6 628 
animals per genotype. WT: black bars, KO: gray bars.   629 
Fig. 6. Usp2-KO mice have normal blood pressure. Telemetry measurements were performed 630 
on 5 KO and 5 control animals under LSD (A), NSD (B) and HSD (C) dietary conditions. 631 
Data are presented as means ± SD of day and night periods. WT: black bars, KO: gray bars; 632 
SBP : Systolic blood pressure, DBP: Diastolic blood pressure. 633 
Fig. 7. Dietary Na+ intake does not influence Usp2-45 expression in the WT mouse CCD. 634 
Usp2-45 (A) and Sgk1 (B) mRNA expression was assayed by real-time semi-quantitative 635 
PCR in microdissected CCD of animals fed Low (LSD), Normal (NSD) or High Sodium 636 
(HSD) diets. Data are means ± SD of 6-7 animals per condition. Statistical significance was 637 
tested by One-Way ANOVA and post-hoc two-tailed T-test using the Holm-Sidak correction 638 
for multiple testing *: p<0.05; **: p<0.01. 639 
 640 
 641 
 642 
27 
 
 643 
Table 1
Pouly et al.
NSD3days LSD7days HSD7days
WT KO WT KO WT KO
 Metabolism
BodyWeight %ofinitial 106.12 ± 2.88 104.35 ± 2.93 117.0 ± 3.2 113.8 ± 2.9 99.9 ± 2.6 96.6 ± 3.4
Waterconsuption ml/gBW /24h 0.211 ± 0.102 0.181 ± 0.063 0.294 ± 0.175 0.194 ± 0.077 0.544 ± 0.062 0.433 ± 0.036
Foodconsumption g/gBW /24h 0.198 ± 0.033 0.192 ± 0.023 0.173 ± 0.016 0.158 ± 0.028 0.156 ± 0.009 0.157 ± 0.007
Urinevolume
ml/gBW /24h 0.081 ± 0.047 0.074 ± 0.016 0.089 ± 0.016 0.065 ± 0.023 0.249 ± 0.054 0.209 ± 0.019
ml/mldrunk /24h 0.847 ± 0.345 0.966 ± 0.205 0.881 ± 0.283 0.905 ± 0.398 0.961 ± 0.181 1.011 ± 0.110
Fecesmass
g/gBW /24h 0.026 ± 0.004 0.025 ± 0.003 0.022 ± 0.003 0.018 ± 0.002 0.023 ± 0.002 0.024 ± 0.004
g/geaten /24h 0.293 ± 0.054 0.293 ± 0.047 0.270 ± 0.024 0.239 ± 0.044 0.320 ± 0.018 0.331 ± 0.039
 Plasma
plasmaNa+ mM 146.3 ± 3.2 146.8 ± 1.7 146.1 ± 5.7 145.2 ± 6.7
plasmaK+ mM 5.9 ± 0.6 5.4 ± 0.2 6.1 ± 1.0 5.9 ± 0.4
plasmaAldosterone pg/ml 567.9 ± 372 573.7 ± 369.3 101.3 ± 83.1 144.1 ± 89.5
 Urine
Osmolality mOsm/kg 2203 ± 597 2542 ± 902 1723 ± 247 1760 ± 255
Creatinine μmol/gBW/24h 0.166 ± 0.043 0.183± 0.036 0.164 ± 0.009 0.146 ± 0.025 0.178 ± 0.023 0.181 ± 0.012
Na+ excretionrate μmol/gBW/24h 11.6 ± 2.6 12.7± 2.3 1.1 ± 0.3 1.1 ± 0.5 124 ± 25.2 109 ± 3.1
K+ excretionrate μmol/gBW/24h 31.9 ± 7.1 32.6± 5.9 29.6 ± 1.7 22.9 ± 4.8 26.1 ± 3.2 25.5 ± 1.2
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